Stonebridge Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$902K |
| 2 |
Merck
MRK
|
+$720K |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$700K |
| 4 |
Sabra Healthcare REIT
SBRA
|
+$454K |
| 5 |
Baker Hughes
BKR
|
+$444K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$1.62M |
| 2 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
+$1.36M |
| 3 |
Chevron
CVX
|
+$1.12M |
| 4 |
SLB Ltd
SLB
|
+$623K |
| 5 |
Williams-Sonoma
WSM
|
+$578K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.72% |
| 2 | Healthcare | 17.32% |
| 3 | Industrials | 14.22% |
| 4 | Energy | 11.1% |
| 5 | Consumer Staples | 8.75% |
Similar funds
Stonebridge Capital Management's Q4 2017 Portfolio in Review
As of Q4 2017, Stonebridge Capital Management held 145 positions worth $281M, up 5.8% from $266M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Stonebridge Capital Management withdrew a net $10.5M in Q4 2017, closing 6 positions and reducing 65 holdings. Its most notable exit was Envision Healthcare Holdings Inc, an estimated $1.36M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Stonebridge Capital Management opened a new position in Regeneron Pharmaceuticals worth $634K.
- Stonebridge Capital Management's largest Q4 2017 buy was Regeneron Pharmaceuticals: 1,728 shares worth $634K.
- Stonebridge Capital Management added most to Gilead Sciences in Q4 2017, an estimated $902K increase.
- Stonebridge Capital Management's biggest Q4 2017 reduction was Qualcomm, cutting an estimated $1.62M.
- Stonebridge Capital Management fully exited Envision Healthcare Holdings Inc in Q4 2017, selling an estimated $1.36M.
- Stonebridge Capital Management's ten largest holdings make up 36% of its $281M portfolio in Q4 2017.
- Stonebridge Capital Management opened 5 new positions and closed 6 in Q4 2017.
- Stonebridge Capital Management's portfolio value rose 5.8% quarter-over-quarter to $281M.
Based on Stonebridge Capital Management's 13F filing for Q4 2017, filed 29 Jan 2018.